# Apathy in Dementia Methylphenidate Trial 2

> **NCT02346201** · PHASE3 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 200 (actual)

## Conditions studied

- Apathy
- Alzheimer's Disease

## Interventions

- **DRUG:** Methylphenidate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02346201
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346201, "Apathy in Dementia Methylphenidate Trial 2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02346201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*